Glucagon-like peptide-1 agonism - GLP-1, common in obesity medicines - is not essential to weight management, according to preclinical research led by Richard DiMarchi and Matthias Tschöp, with funding from their startup company Bluewater Biosciences.
so horrifyingly human-hostile :( I sometimes get annoyed how car-centric European cities are, but it’s so much worse in the USA :(